AEM
Home Help [Feedback] [For Subscribers] [Archive] [Search] --
AEM Accepts, published online ahead of print on 1 February 2008
This Article
Right arrow Full Text (PDF)
Right arrow Other Versions of this Article:
AEM.02740-07v1
74/6/1757    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Heithoff, D. M.
Right arrow Articles by Mahan, M. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Heithoff, D. M.
Right arrow Articles by Mahan, M. J.
Agricola
Right arrow Articles by Heithoff, D. M.
Right arrow Articles by Mahan, M. J.

 Previous Article  |  Next Article 

Appl. Environ. Microbiol. doi:10.1128/AEM.02740-07
Copyright (c) 2008, American Society for Microbiology and/or the Listed Authors/Institutions. All Rights Reserved.

Human Salmonella Clinical Isolates That Are Distinct From Those of Animal Origin

Douglas M. Heithoff, William R. Shimp, Patrick W. Lau, Golnaz Badie, Elena Y. Enioutina, Raymond A. Daynes, Barbara A. Byrne, John K. House, and Michael J. Mahan*

Dept. of Molecular, Cellular and Developmental Biology, University of California, Santa Barbara, CA 93106, USA; Department of Pathology, University of Utah School of Medicine, Salt Lake City, UT 84132; School of Veterinary Medicine, Department of Pathology, Microbiology, and Immunology, University of California, Davis, CA 95616; University of Sydney, Faculty of Veterinary Science, Camden NSW 2570

* To whom correspondence should be addressed. Email: mahan{at}lifesci.lscf.ucsb.edu.


   Abstract

The global trend towards intensive livestock production has led to significant public health risks and industry-associated losses due to an increased incidence of disease and contamination of livestock-derived food products. A potential contributing factor to these health concerns is the prospect that selective pressure within a particular host may give rise to bacterial strain variants that exhibit enhanced fitness in the current host relative to the parental host from which the strain was derived. Here we assessed 184 Salmonella enterica human and animal clinical isolates for their virulence capacity in mice, and for the presence of the Salmonella virulence plasmid, encoding the SpvB actin cytotoxin required for systemic survival, and Pef fimbriae implicated in adherence to murine intestinal epithelium. All (21/21) Typhimurium clinical isolates derived from animals were virulent in mice, whereas many (16/41) Typhimurium isolates derived from human salmonellosis patients lacked this capacity. Additionally, many (10/29) Typhimurium isolates derived from gastroenteritis patients did not possess the Salmonella virulence plasmid, contrary to all animal or human bacteremia isolates tested. Last, among Typhimurium isolates that harbored the Salmonella virulence plasmid, 6 of 31 derived from human salmonellosis patients were avirulent in mice, which is in contrast to the virulent phenotype exhibited by all animal isolates examined. These studies suggest that Salmonella isolates derived from human salmonellosis patients are distinct from those of animal origin. Characterization of these bacterial strain variants may provide insight into their relative pathogenicity as well as to the development of treatment and prophylactic strategies for salmonellosis.




This article has been cited by other articles:




Home Help [Feedback] [For Subscribers] [Archive] [Search] --
J. Bacteriol. Microbiol. Mol. Biol. Rev. Eukaryot. Cell All ASM Journals

Copyright © 2008 by the American Society for Microbiology. All rights reserved.